FDA Commissioner Dr Marty Makary tried to allay industry concerns about recent cuts and outlined his agenda for the future.

Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for zagociguat.

The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.

Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).

Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...

India has proposed increasing US manufacturing by Indian pharma providers of APIs and the final stages of drug processing ...

Bavarian Nordic has sold a PRV for $160m, a day after the FDA announced a new scheme utilising the fast-track tickets.

NHS England chair Penny Dash shared her views on European healthcare during a fireside discussion at HLTH Europe in Amsterdam ...

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...

Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...

Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...